Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.283
Data as of Oct 24
 -0.016 / -5.35%
Today’s Change
0.19
Today|||52-Week Range
0.55
+6.79%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$55.3M

Company Description

Hemispherx Biopharma, Inc. is a biopharmaceutical company, which engages in treating and preventing chronic viral and immune-based disorders through the development and manufacturing of compounds that enhance the natural immune system of the human body. Its products include Alferon N Injection and the experimental immunotherapeutic/antiviral Ampligen. Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. Ampligen includes application as a treatment for Chronic Fatigue Syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Philadelphia, PA.

Contact Information

Hemispherx Biopharma, Inc.
One Penn Center
Philadelphia Pennsylvania 19103
P:(215) 988-0080
Investor Relations:
(518) 398-6222

Employees

Shareholders

Mutual fund holders3.09%
Other institutional2.81%
Individual stakeholders2.32%

Top Executives

William A. CarterChairman, President, Chief Executive Officer & CSO
Wayne S. SpringateSenior Vice President-Operations
Thomas Kenwood EquelsExecutive Vice Chairman, CFO & Secretary
David R. StrayerCMO, Medical Director & Head-Regulatory Affairs
Ralph Christopher CavalliVice President-Quality Control

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.